Cecilia M. Fernández-‐Llamazares & col.
502
38. Krupicka, M.I.; Bratton, S.L.; Sonnenthal, K.; Goldstein, B. Impact of a pediatric clinical
pharmacist in the pediatric intensive care unit. Crit Care Med 30(4), 919-‐21 (2002 Apr).
39. Neubert, A.; Wong, I. C.; Bonifazi, A.; Catapano, M.; Felisi, M.; Baiardi, P.; et al. Defining off-‐
label and unlicensed use of medicines for children: Results of a delphi survey. Pharmacol
Res 58(5-‐6), 316-‐22 (2008 Nov-‐Dec).
40. Draft guidelines on preventable medication errors. Am J Hosp Pharm 49(3), 640-‐8 (1992
Mar).
41. Understanding and preventing drug misadventures. Proceedings of a conference. Chantilly,
Virginia, October 21-‐23, 1994. Am J Health Syst Pharm 52(4), 369-‐416 (1995 Feb 15).
42. ASHP guidelines on a standardized method for pharmaceutical care; American society of
health-‐system pharmacists. Am J Health Syst Pharm 53(14), 1713-‐6 (1996 Jul 15).
43. Robertson, K. E. Process for preventing or identifying and resolving problems in drug
therapy. Am J Health Syst Pharm 53(6), 639-‐50 (1996 Mar 15).
44. Strand, L. M.; Guerrero, R. M.; Nickman, N. A.; Morley, P. C. Integrated patient-‐specific
model of pharmacy practice. Am J Hosp Pharm 47(3), 550-‐4 (1990 Mar).
45. Smith, W. E.; Benderev, K. Levels of pharmaceutical care: A theoretical model. Am J Hosp
Pharm 48(3), 540-‐6 (1991 Mar).
46. Haupt, M. T.; Bekes, C. E.; Brilli, R. J.; Carl, L. C.; et al. Guidelines on critical care services and
personnel: Recommendations based on a system of categorization of three levels of care.
Crit Care Med 31(11), 2677-‐83 (2003 Nov).
47.
el Event
from:
.
